Hengrui
Manufacturing · China · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Shanghai, Shanghai, ChinaPhone Number
+86 2131013077Website
www.hengruicorp.comRevenue
$16.6 MillionIndustry
About Hengrui
Hengrui Org Chart
Is Hengrui your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Hengrui has new funding data
Product Launch: Get notified when Hengrui launches new products
Check if Hengrui has recently received funding, and reach out quickly before it becomes old news!
Check out if Hengrui is spiking on competitors!
Hengrui, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Hengrui had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Hengrui recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Hengrui
Recommended Actions
Reach out to Masked Content who joined Hengrui as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Hengrui is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Hengrui is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Hengrui.
Hengrui Tech Stack
A closer look at the technologies used by Hengrui
Hengrui News & Media
Hengrui Pharma Presents More Than 90 Oncology Studies at ASCO 2026, Highlighting Progress Across Multiple Tumor Types
SHANGHAI, June 1, 2026 /PRNewswire/ -- The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was held in Chicago from May 29 to June 2 (local time). As one of the world's leading oncology conferences, the ASCO Annual Meeting serves as a key venue for presenting advances in...Hengrui Pharma Presents More Than 90 Oncology Studies at ASCO 2026, Highlighting Progress Across Multiple Tumor Types
SHANGHAI, June 1, 2026 /PRNewswire/ -- The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was held in Chicago from May 29 to June 2 (local time). As one of the world's leading oncology conferences, the ASCO Annual Meeting serves as a key venue for presenting advances in cancer research and clinical development. This year, Hengrui Pharma presented more than 90 studies spanning multiple tumor types and therapeutic modalities. According to statistics, 94 ChineseHengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth
SHANGHAI, April 22, 2026 /PRNewswire/ -- Hengrui Pharma reported steady growth in the first quarter of 2026. In Q1 2026, the Company recorded revenue of RMB 8.14 billion, up 12.98% year-over-year, while net profit attributable to shareholders increased by 21.78% to RMB 2.28 billion....Hengrui Pharma Announces Strong 2025 Annual Results
HONG KONG, Mar 25, 2026 - (ACN Newswire) - On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled by its dual strategy of innovation and globalization. Revenue increased 13.02% year-on-year to RMB 31.63 billion, and net profit attributable to shareholders increased by 21.69% to RMB 7.71 billion. Innovation remained the engine of Hengrui’s growth: Innovative drug sales increased by 26.09% year-on-year to RMB 16.34 billion, contrib
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hengrui
Established in 2014, Hengrui Corporation is a globally leading scientific and technology company chiefly engaged in research and development (R&D), manufacturing and engineering of composites (mainly in carbon fiber), serving multiple industries including automotive, aerospace, industrial equipment, electronic digitals, medical device and high-end... Read More